Laurus Labs receives EIR for API facility of Unit 2

Capital Market

Last Updated : May 20 2017 | 12:08 AM IST

On successful completion of USFDA inspection

Laurus Labs announced that the API facility of the Unit 2 has completed successful USFDA inspection without any 483 and the formulations unit in the same facility received EIR (Establishment Inspection Report) on 18 May 2017

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

NESCO plans sub-division of equity shares

Board of Mahindra Holidays & Resorts India recommends bonus issue

Cholamandalam Investment & Finance Company allots 4659 equity shares

Board of Simplex Trading & Agencies considers change in registered office

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 19 2017 | 6:21 PM IST

Explore News

Market LIVE Stock Market Crash Latest News LIVE Market Today Stocks To Watch Today Gold and Silver Price Today Mamata Machinery IPO Concord Enviro IPO IPO News Business Standard at 50